Stem Cell Treatment for Eye Diseases Cost in India

The cost varies by condition but typically ranges from $4,000 to $8,000 in India, which is significantly lower than Western countries while maintaining high medical standards.

This innovative therapy often targets optic nerve atrophy, retinitis pigmentosa, macular degeneration, and glaucoma by attempting to regenerate damaged ocular tissues.

Success rates vary based on disease severity, but many patients report stabilized vision and halted progression, with improvement rates generally observed between 60% to 70%.

Yes, it is generally safe when performed by certified specialists. India follows stringent medical protocols utilizing autologous stem cells to minimize rejection and side effects.

The complete procedure usually requires a 7 to 14-day stay in India. This includes initial evaluations, stem cell extraction, processing, the administration phase, and follow-up.

Medical professionals predominantly use autologous bone marrow-derived or adipose-derived mesenchymal stem cells, ensuring high biocompatibility and ethical compliance.

Most patients can resume light activities within a few days. However, noticeable visual improvements and cellular regeneration may take three to six months to fully manifest.

Ideal candidates have partial vision loss with viable optic pathways. A thorough remote consultation and medical record review by Indian specialists will determine eligibility.

While stem cells aim to permanently repair cellular damage, degenerative diseases can still progress. Many patients experience long-lasting relief, but future boosters may be needed.

The procedure is minimally invasive and performed under local anesthesia. Patients typically experience only mild discomfort or slight pressure during the retrobulbar injections.

International patients must apply for an e-Medical Visa. You will need an invitation letter from your chosen accredited Indian medical facility to complete the application process.